Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSCI | AZN | AMGN | GILD | VRTX |
| Company | Cosciens Biopharma Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.42 | 69.96 | 269.48 | 105.85 | 428.68 |
| High | 3.69 | 70.21 | 272.46 | 106.67 | 434.19 |
| Low | 3.42 | 69.91 | 269.13 | 105.58 | 427.43 |
| Last | 3.52 | 70.29 | 271.53 | 106.09 | 431.79 |
| Change | -0.10 | +0.34 | -0.37 | -0.65 | -2.24 |
| % Change | -2.71% | +0.49% | -0.14% | -0.61% | -0.52% |
| Volume | 1,115 | 539,887 | 755,743 | 483,865 | 111,890 |
| 20-Day Average Volume | 3,910 | 5,077,593 | 2,828,449 | 8,704,497 | 2,079,035 |
| Previous Close | 3.61 | 69.95 | 271.90 | 106.74 | 434.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.49 | 69.63 | 275.41 | 103.07 | 455.26 |
| 20-Day Raw Stochastic | 72.63% | 59.34% | 30.50% | 81.05% | 17.83% |
| 20-Day Relative Strength | 56.83% | 50.59% | 43.50% | 52.83% | 39.75% |
| Weighted Alpha | -32.93 | -10.46 | -14.27 | +55.80 | -9.22 |
| Today's Opinion | 72% Buy | 72% Sell | 100% Sell | 64% Buy | 56% Sell |
| Previous Opinion | 56% Buy | 72% Sell | 88% Sell | 64% Buy | 56% Sell |
| Last Month's Opinion | 48% Sell | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.60% since 05/14/25 | +1.78% since 05/16/25 | -0.61% since 05/16/25 | +4.01% since 05/16/25 | -1.20% since 05/16/25 |
| Low | 3.14 on 05/15/25 | 68.68 on 05/19/25 | 269.10 on 05/22/25 | 102.84 on 05/19/25 | 428.68 on 05/23/25 |
| High | 3.61 on 05/22/25 | 70.98 on 05/21/25 | 276.90 on 05/20/25 | 109.25 on 05/20/25 | 448.00 on 05/20/25 |
| 1-Month | |||||
| %Chg | +19.07% since 04/22/25 | +2.23% since 04/23/25 | -2.57% since 04/23/25 | +0.22% since 04/23/25 | -11.99% since 04/23/25 |
| Low | 3.10 on 04/23/25 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 3.80 on 05/05/25 | 72.69 on 05/06/25 | 292.00 on 04/30/25 | 109.25 on 05/20/25 | 510.77 on 04/30/25 |
| 3-Month | |||||
| %Chg | +32.86% since 02/21/25 | -5.64% since 02/21/25 | -10.65% since 02/21/25 | -3.04% since 02/21/25 | -10.50% since 02/21/25 |
| Low | 1.96 on 03/13/25 | 61.24 on 04/09/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 4.61 on 03/19/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | +23.30% since 11/22/24 | +6.71% since 11/22/24 | -8.07% since 11/22/24 | +18.21% since 11/22/24 | -3.90% since 11/22/24 |
| Low | 1.96 on 03/13/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 88.57 on 01/10/25 | 377.85 on 12/19/24 |
| High | 4.61 on 03/19/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,371 | 216,932,224 | 146,202,256 | 132,776,968 | 111,457,600 |
| Shares Outstanding, K | 3,147 | 3,101,247 | 537,706 | 1,243,929 | 256,797 |
| Annual Sales | 9,590,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -15,310,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 1,500,000 | 13,588,000,000 | 8,149,000,000 | 6,667,000,000 | 2,770,200,000 |
| Last Quarter Net Income | -3,660,000 | 2,921,000,000 | 1,730,000,000 | 1,315,000,000 | 646,300,000 |
| 60-Month Beta | 0.89 | 0.40 | 0.51 | 0.26 | 0.51 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 05/13/25 | 1.24 on 04/29/25 | 4.90 on 05/01/25 | 1.81 on 04/24/25 | 4.06 on 05/05/25 |
| Latest Earnings Date | 05/13/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 05/16/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.13 | 13.07 | 13.92 | 0.00 |